Life Science Manufacturer, Taro Pharmaceuticals Inc., plans to double its production capability by investing in new manufacturing and R&D equipment at its Brampton, Ontario, Canada
, production facility, creating up to 140 jobs.
The Province of Ontario is contributing $7 million toward the $247 million project, which will increase Taro’s plant capacity by 50 per cent and potentially double the number of products it brings to market. Integrating R&D into the manufacturing process will help the firm supply its clients more efficiently and stay competitive. Through this project, Taro will anchor its facility in Ontario, keeping highly skilled jobs
in the province, while reducing supply chain and transportation costs.
“This funding will help Taro Pharmaceuticals increase its global competitiveness while keeping highly skilled jobs here in Ontario. We are committed to partnering with companies like Taro to create jobs, attract investment and boost our economic strength for generations to come, “ Dr. Eric Hoskins
, Minister of Economic Development, Trade and Employment.
“The government’s support provides a great opportunity for the community and for our company. This will help us further increase our manufacturing capacity to supply our customers, and also anchor the facility in Ontario rather than elsewhere in the world. Our team looks forward to further expanding our line of high-quality products and reducing supply chain and transportation costs to stay competitive,” said Daryl LeSueur, Vice President, Head of Operations for Taro Pharmaceuticals Inc.